Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-07

Clinical Trial Update: DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS

View source ↗

Summary

A completed clinical trial investigating speech degradation as an indicator of physiological degeneration in amyotrophic lateral sclerosis; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Amyotrophic Lateral Sclerosis | Status: COMPLETED | Results posted: 2020-08-07